From the ∗Department of Nuclear Medicine, CHU UCL Namur, Godinne Site, Université Catholique de Louvain

Departments of †Nuclear Medicine

‡Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Université Catholique de Louvain, Leuven, Belgium.

Received for publication April 27, 2023; revision accepted August 6, 2023.

Conflicts of interest and sources of funding: none declared.

Author Contributions: Drafting the article or revising it critically for important intellectual content (A.C.); final approval of the version to be submitted (A.C., V.R., O.G., S.B.).

Correspondence to: Amine Chaouki, MD, Nuclear Medicine Department, CHU UCL Namur, Godinne site, Université Catholique de Louvain, Dr G. Therasse 1 Avenue, 5530 Yvoir, Belgium. E-mail: [email protected].